PATENT CLAIM ANALYSIS

Application Number: 15752004
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "210180"]

Abstract:
Disclosed herein, in part, are fumagillol compounds and methods of use in treating medical disorders, such as obesity. Pharmaceutical compositions and methods of making fumagillol compounds are provided. The compounds are contemplated to have activity against methionyl aminopeptidase 2.

Claim (Index 24):
The compound of  claim 23 , wherein R i  and R j  are independently selected from the group consisting of hydrogen and C 1-3 alkyl, or R i  and R j  taken together with the nitrogen to which they are attached form a 4-6 membered heterocyclic ring, which may have an additional heteroatom selected from the group consisting of N and O; wherein the heterocyclic ring may be optionally substituted on carbon by one, two, or more fluorine atoms; and wherein if said heterocyclic ring contains a \u2014NH moiety that nitrogen may be optionally substituted by C 1-3 alkyl; wherein C 1-3 alkyl may optionally be substituted by one or more fluorine atoms.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 88.0
- Lexical Diversity: 1.40625
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15827074', '15354834', '15796519', '14974033', '15769414']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8717923178718078
- 35 USC 102 Novelty (BERT): 0.6303227842559663
- Combined Prediction Score: 0.8476453645102237
- Mean Citation Score: 462.634208
- Max Citation Score: 606.9383
- Similarity Product: 480.29462271554473

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test